Peyronie's disease

Streamlined management of Peyronie’s disease
Streamlined management of Peyronie’s diseaseIn this article, we describe our thought processes in treating patients with Peyronie's disease, which are summarized in an algorithm.
Sexual Function/Dysfunction: Mixed results with CCH in Peyronie'sSexual function/dysfunction topics discussed at the 2016 AUA included the findings of multiple studies on the effects of collagenase clostridium histolyticum (Xiaflex) treatment for Peyronie's disease, causes and treatments for ED, along with a study on patient satisfaction with implantable penile prostheses.
How number of Peyronie’s Tx cycles affects outcomesIn a study of intralesional collagenase clostridium histolyticum, mean curvature was reduced most dramatically after the first cycle, researchers reported.
Study: Minority of urologists treat Peyronie’s diseasePeyronie’s disease (PD) is surgically treated by a minority of urologists, and urologists who subspecialize in andrology perform a disproportionate number of procedures to treat the condition. Those were among the findings of a case-log analysis that was presented at the 2015 AUA annual meeting in New Orleans and subsequently published in Urology (2016; 87:205-9).
AUA Peyronie’s guideline: Dr. Burnett offers highlightsThe recently published AUA practice guideline on Peyronie’s disease provides current clinical principles on diagnosis and treatment of a highly prevalent and clinically significant condition, according to the co-chair of the multidisciplinary panel that developed the guideline.
Best of AUA 2015: PCa surveillance, surgical controversies create buzzUrology Times’ “Best of AUA 2015” report provides a guide to the meeting’s take-home messages in 15 therapeutic areas—an information-packed, condensed summary of the top papers and presentations.
Best of AUA 2014: Sexual Function/Dysfunction
Best of AUA 2014: Sexual Function/DysfunctionLandon Trost, MD, presents the take home messages on sexual function/dysfunction from the AUA annual meeting in Orlando, FL, including studies of clostridium collagenase histolyticum (CCH [XIAFLEX]).
Best of AUA 2014: Basic Science ResearchK.C. Balaji, MD, presents the take home messages on basic science research from the AUA annual meeting in Orlando, FL.
Penile implant extrusion prompts litigationOther cases discussed in this edition of "Malpractice Consult" include cecum perforated during prostatectomy, injections fail to improve Peyronie's disease, and dementia diagnosis blamed on urologic procedure.
Peyronie’s treatment shows efficacy in phase III studiesIntralesional injection of collagenase clostridium histolyticum (CCH [XIAFLEX]) improves the physical and psychological aspects of Peyronie’s disease in men regardless of erectile dysfunction severity and whether they have a history of prior treatment or prostatectomy, according to a recent study.